Abstract:Aim To study the pharmacokinetics characteristics of galanthamine hydrohromide sustained release tablets and conventional tablets in healthy volunteers after a single and multiple oral doses. MethodsA single and multiple oral doses of galanthamine hydrohromide sustained release tablets and conventional tablets were given to 20 healthy male volunteers in a randomized cross-over study. We developed an LC-MS assay using naloxone as the internal standard to determine the plasma concentrations of galanthamine, calculate the pharmacokinetic parameters and evaluate the relative bioavailability and sustained release characteristics of galanthamine hydrohromide sustained release tablet. Results The pharmacokinetic parameters of the sustained release tablet and conventional tablet obtained from the single-dose study were as follows: the HVD_12 C_max(time span during which the plasma concentration is at least half of the C_max value)were (15.4±1.7) h and (5.4±2.5) h, the retard quotients (R△,the HVD_12 C_max ratio of sustained release tablets to conventional tablets) of sustained release tablet was 3.4±1.4, the T_max were (4.4±1.5) h and (1.3±1.2) h, the C_max were (27.5±2.9) μg·L-1 and (53.7±12.7) μg·L-1.Results showed significant sustained release characteristics of the sustained release tablet. The relative bioavailability of the sustained release tablet was (95.9±14.2) %。The pharmacokinetic parameters of the sustained release tablet and conventional tablet obtained from the multi-dose study were as follows: the T_max were (3.0±1.6) h and (0.9±0.3) h,the CSS_max were (58.8±9.4) μg·L-1 and (52.0±6.9) μg·L-1,the CSS_min were (16.2±4.0) μg·L-1 and (22.5±5.0) μg·L-1,the C_av were (39.0±3.9) μg·L-1 and (37.1±5.0) μg·L-1,the DF were 1.1 ±0.3 and 0.8±0.1, respectively. Results of two one-side t test showed that AUC_SS、CSS_max、C_av of two tablets were bioeqivalent. Conclusion Results showed that the sustained release tablet and the regular tablet were bioequivalent in absorbed extent, and the sustained release tablet exhibited a good retarding effect in release.

Galanthamine Hydrobromide:Pharmacokinetics and Bioequivalence in Healthy Volunteers

Bioequivalence of galanthamine hydrobromide released capsule in healthy volunteers

Pharmacokinetics and Bioequivalence Studies of Galantamine Hydrobromide Dispersible Tablet in Healthy Male Chinese Volunteers

The pharmacokinetics and sustained release characteristics evaluation of galanthamine hydrohromide sustained release tablet in healthy volunteers

Determination of Huperzine A in Human Plasma by LC-MS/MS and Its Application to Relative Bioavailability of Huperzine A Tablets

Studies on High-Performance Liquid Chromatographic Determination of Galanthamine in Human Plasma with UV Detection and Its Pharmacokinetics

Bioequivalence of Glucosamine Hydrochloride Preparations in Healthy Volunteers

Study on the Bioequivalence of Memantine Hydrochloride Tablets in Chinese Healthy Volunteers

Determination of Glucosamine Sulfate in Human Plasma by LC-MS/MS and Study on Its Bioequivalence

Bioequivalence of glycyrrhizin capsules by HPLC-MS

Study on Bioequivalence of Mesilate Phentolamine Oral Solution in Chinese Healthy Volunteers

Bioequivalence of 2 amlodipine besylate tablets by LC-MS-MS in healthy Chinese volunteers

HPLC determination of Ganciclovir in the human plasma and its bioequivalence

Relative Bioavailability and Bioequivalence of Anmaweiming Tablets in Healthy Volunteers

Bioequivalence of Repaglinide in Healthy Volunteers

Bioequivalence of glipizide orally disintegrating tablets in healthy volunteers

Bioequivalence of gliclazide tablets in Chinese healthy volunteers

Pharmacokinetics and bioequivalence of nateglinide in healthy volunteers

Study on bioequivalence and pharmacokinetics of compound glycyrrhizin capsules in healthy volunteers

Study of the Bioequivalence of Gliclazide in Chinese Healthy Volunteers

Bioequivalence of Glipizide Controlled-Release Tablets in Chinese Healthy Volunteers